European CHMP Adopts Positive Opinion for Gilead's Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults
COMUNICADO: CHMP Recommends Approval of Lilly's Ramucirumab (CYRAMZA(TM)) for Advanced Gastric Cancer After Prior Chemotherapy (1)
MOVENTIG® (naloxegol) RECEIVES POSITIVE CHMP OPINION IN THE EU FOR THE TREATMENT OF ADULTS WITH OPIOID-INDUCED CONSTIPATION
Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly
Pharma Stocks Review - AbbVie, Merck, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb
Editor Note: For more information about this release, please scroll to bottom.
LONDON, September 25, 2014
Program expands access to care supporting the Diagnostics Access Initiative
PLEASANTON, Calif., Sept.
KING OF PRUSSIA, Pa., Sept. 25, 2014 /PRNewswire/ -- Universal Health Services, Inc.
Shire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices
WHIPPANY, N.J., Sept. 24, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.